glp 1 drugs oral list of medications GLP-1/GIP Receptor Agonists and Diabetic Retinopathy: What ODs Should Oral GLP-1 Medication Helps Patients
Description
N.LoganathanG.AhmadA.HeringB
In the real-world setting, persistence with GLP-1 RA therapy has been found to range between 40% and 60% and between 34% and 67% at 180 and 360 days, respectively [23,24,25]
The timing depends on the FDA's rigorous review process of the clinical trial data on retatrutide once it is submitted, however, it is unlikely to be approved and available until at least late 2026 and possibly into 2027 or 2028
That led them to examine whether GLP-1s might affect bone and other connective tissue more broadly
[PubMed] [Google Scholar] 267.Knudsen L.B., Lau J
